Search
Patritumab deruxtecan
go.drugbank.com/drugs/DB21996InvestigationalPatritumab deruxtecan is under investigation in clinical trial NCT06596694 (Study of Patritumab Deruxtecan in Participants With Gastrointestinal Cancers (MK-1022-011) (HERTHENA-PanTumor02)).
Categories: Amino Acids, Peptides, and Proteins, Antineoplastic and Immunomodulating AgentsEmepronium
go.drugbank.com/drugs/DB13505ExperimentalCategories: Hypnotics and Sedatives, Alimentary Tract and MetabolismEpimestrol
go.drugbank.com/drugs/DB13386ExperimentalCategories: Genito Urinary System and Sex Hormones, Sex Hormones and Modulators of the Genital SystemCBP-501
go.drugbank.com/drugs/DB17277InvestigationalCategories: Enzymes and Coenzymes, Amino Acids, Peptides, and ProteinsBoldenone undecylenate
go.drugbank.com/drugs/DB14639ExperimentalIllicitVet approvedCategories: Hormones, Hormone Substitutes, and Hormone AntagonistsLys-plasminogen
go.drugbank.com/drugs/DB32870ExperimentalLys-plasminogen is a truncated form of natural human plasminogen.
Categories: Enzymes and Coenzymes, Amino Acids, Peptides, and ProteinsCobalt Co-60
go.drugbank.com/drugs/DB15374ExperimentalCobalt Co-60 is under investigation in clinical trial NCT02891083 (Adjuvant Therapies or Surgery Alone for High Risk pN0 Esophageal Cancer).
Menaquinone 7
go.drugbank.com/drugs/DB13075InvestigationalMenaquinone 7 is under investigation in clinical trial NCT00402974 (The Effect of Vitamin K Supplementation on Osteocalcin Carboxylation in Healthy Children).
Lazuvapagon
go.drugbank.com/drugs/DB19046InvestigationalLazuvapagon is under investigation in clinical trial NCT03116191 (Trial of SK-1404 for Nocturia Due to Nocturnal Polyuria in Japanese Subjects).
Synonyms: (4s)-n-((2s)-1-hydroxypropan-2-yl)-methyl-1-(2-methyl-4-(3-methyl-1h-pyrazol-1-yl)benzoyl)-2,3,4,5-tetrahydro-1h-1-benzazepine-4-carboxamide, 1h-1-benzazepine-4-carboxamide, 2,3,4,5-tetrahydro-n-((1s)-2-hydroxy-1-methylethyl)-4-methyl-1-(2-methyl-4-(3-methyl-1h-pyrazol-1-yl)benzoyl)-, (4s)-NBQ72S
go.drugbank.com/drugs/DB26052InvestigationalNBQ72S is under investigation in clinical trial NCT06810804 (A Phase IIa Study to Evaluate NBQ72S).